首页> 外文学位 >Molecular basis of the Arf and Hdm2 interaction.
【24h】

Molecular basis of the Arf and Hdm2 interaction.

机译:Arf和Hdm2相互作用的分子基础。

获取原文
获取原文并翻译 | 示例

摘要

Understanding the interaction of Arf and Hdm2 has recently become a central issue in cancer biology. In response to hyperproliferative signals, p14 Arf stabilizes p53 by binding to Hdm2 and inhibits the ubiquitination and subsequent proteosome-dependent degradation of p53. The medical importance of the Arf-Hdm2-p53 regulatory system is highlighted by the finding that either p53 or p14Arf are lost or modified in virtually all human cancers. Isolated Arf and Hdm2 domains are dynamically disordered in solution, yet they retain the ability to interact in vitro and in cellular assays. Upon binding, domains of both Arf and Hdm2 undergo a dramatic transition forming extended structures comprised of β-strands. Domains from both proteins are necessary and sufficient for the formation of the highly stable extended β structures. We have mapped sites within Arf and Hdm2 that interact at a resolution of 5 amino acids using surface plasmon resonance (SPR). SPR and circular dichroism (CD) spectropolarimetry confirm the presence of multiple interaction domains within each protein. Both p14Arf (human) and p19Arf (mouse) interact with Hdm2 through two short motifs present in their N-termini. The Arf interacting region of Hdm2 is also composed of two short sequences located in the central acidic domain, between residues 235–264 and 270–289. The binding-induced structural transition is also induced by short peptides, 15 amino acids in length, that contain the binding motifs. Micro-injection and live cell imaging of proteins tagged with fluorescent labels was used to confirm the in vivo function of the interaction domains. Arf and Hdm2 thus appear to interact through a novel mechanism that exerts control over the cell division cycle. The novel molecular mechanism of interaction and the limited size of the protein domains responsible provide opportunities for the development of anticancer therapeutics. Analysis of the β-assemblies, using electron microscopy, showed that extended fibrils were formed by short peptides containing the high affinity binding site. This is the first report on β-fibrils in which domains from two proteins are involved in the formation of extended structures and may provide a platform for the assembly of macromolecular complexes useful in a wide range of nanotechnologies.
机译:最近,了解Arf和Hdm2的相互作用已成为癌症生物学的中心问题。对过度增殖的信号作出响应,p14 Arf 通过与Hdm2结合来稳定p53,并抑制p53的泛素化和随后的蛋白体依赖性降解。发现 p53 p14 Arf 几乎消失或被修饰的发现突显了Arf-Hdm2-p53调节系统的医学重要性。所有人类癌症。分离的Arf和Hdm2域在溶液中是动态无序的,但它们仍具有在体外和细胞试验中相互作用的功能。结合后,Arf和Hdm2的结构域都经历剧烈的过渡,形成由β链组成的延伸结构。来自两种蛋白质的结构域对于形成高度稳定的扩展β结构而言都是必要且充分的。我们在Arf和Hdm2中绘制了使用表面等离振子共振(SPR)以5个氨基酸的分辨率相互作用的位点。 SPR和圆二色性(CD)光谱极谱法证实了每种蛋白质中都存在多个相互作用域。 p14 Arf (人类)和p19Arf(小鼠)都通过Hdm2的N末端中的两个短基元与Hdm2相互作用。 Hdm2的Arf相互作用区域还由位于中央酸性域的两个短序列组成,位于残基235-264和270-289之间。结合诱导的结构转变也由包含结合基序的长度为15个氨基酸的短肽诱导。微注射和活细胞成像的荧光标记标签的蛋白质被用来确认相互作用域的体内功能。因此,Arf和Hdm2似乎是通过一种对细胞分裂周期施加控制的新型机制相互作用的。相互作用的新型分子机制和负责的蛋白质结构域的大小有限,为开发抗癌疗法提供了机会。使用电子显微镜对β-组装体的分析表明,延伸的原纤维是由含有高亲和力结合位点的短肽形成的。这是有关β-原纤维的首次报道,其中两个蛋白质的结构域参与了延伸结构的形成,并可能为组装可用于多种纳米技术的大分子复合物提供平台。

著录项

  • 作者

    Bothner, Brian Paul.;

  • 作者单位

    The University of Tennessee Center for the Health Sciences.;

  • 授予单位 The University of Tennessee Center for the Health Sciences.;
  • 学科 Biology Molecular.; Chemistry Biochemistry.; Health Sciences Oncology.
  • 学位 Ph.D.
  • 年度 2002
  • 页码 183 p.
  • 总页数 183
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 分子遗传学;生物化学;肿瘤学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号